The deal size was increased to $175M in common stock from $150M in common stock. Jefferies and Goldman Sachs acted as joint book running managers for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRVS:
- Corvus Pharmaceuticals price target raised to $32 from $15 at Oppenheimer
- Closing Bell Movers: Netflix down 5% after soft guidance
- Corvus Pharmaceuticals Suspends At-The-Market Equity Program
- Corvus Pharmaceuticals announces $150M common stock offering
- Corvus Pharmaceuticals price target raised to $28 from $16 at Barclays